These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

630 related items for PubMed ID: 16123828

  • 1. Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital.
    Chng WJ, Sum C, Kuperan P.
    Singapore Med J; 2005 Sep; 46(9):450-6. PubMed ID: 16123828
    [Abstract] [Full Text] [Related]

  • 2. [Study on usefulness of different APTT test kit in variable coagulopathy].
    Naito S, Ieko M, Yoshida M, Tarumi T, Nakabayashi T, Nishio H, Atsumi T.
    Rinsho Byori; 2008 Mar; 56(3):195-202. PubMed ID: 18411803
    [Abstract] [Full Text] [Related]

  • 3. Prolonged aPTT after kidney transplantation due to transient lupus anticoagulants.
    Nybo M, Dieperink H, Kristensen SR.
    Nephrol Dial Transplant; 2006 Apr; 21(4):1060-5. PubMed ID: 16384821
    [Abstract] [Full Text] [Related]

  • 4. The investigation of a prolonged APTT with specific clotting factor assays is unnecessary if an APTT with Actin FS is normal.
    Bowyer A, Smith J, Woolley AM, Kitchen S, Hampton KK, Maclean RM, VAN Veen JJ, Makris M.
    Int J Lab Hematol; 2011 Apr; 33(2):212-8. PubMed ID: 20880301
    [Abstract] [Full Text] [Related]

  • 5. [Prevalence of prolonged APTT and lupus anticoagulant in autoimmune thyroid disease].
    Tani Y, Morita M, Noguchi S.
    Rinsho Byori; 1997 Sep; 45(9):899-902. PubMed ID: 9311265
    [Abstract] [Full Text] [Related]

  • 6. [Unsuspected prolonged activated partial thromboplastin time in emergency surgery. Diagnostic and therapeutic guide].
    Barrio J, Peris V, Asensio I, Molina I, López F, García V.
    Rev Esp Anestesiol Reanim; 2002 Oct; 49(8):424-7. PubMed ID: 12455323
    [Abstract] [Full Text] [Related]

  • 7. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism.
    Morelli VM, Rodrigues CA, Noguti MA, Matos MF, da Silveira RC, Ribeiro AA, Lourenço DM.
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):401-5. PubMed ID: 17581313
    [Abstract] [Full Text] [Related]

  • 8. Biological and clinical heterogeneity of lupus and lupus-like anticoagulant in fifty-seven patients.
    Horellou MH, Aurousseau MH, Boffa MC, Conrad J, Wiesel ML, Samama M.
    J Med; 1987 Jul; 18(3-4):199-217. PubMed ID: 3480933
    [Abstract] [Full Text] [Related]

  • 9. A lupus anticoagulant neutralization procedure using the patient's own platelets.
    Carroll P, Ray M, Just S, Hawson G.
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):523-7. PubMed ID: 7841308
    [Abstract] [Full Text] [Related]

  • 10. Activated partial thromboplastin time reagent sensitivity to the presence of the lupus anticoagulant.
    Adcock DM, Marlar RA.
    Arch Pathol Lab Med; 1992 Aug; 116(8):837-40. PubMed ID: 1497465
    [Abstract] [Full Text] [Related]

  • 11. [A patient with hemorrhage originating from an unknown coagulation pathway inhibitor].
    Komiyama Y, Munakata M, Masuda M, Kagawa H, Fukuhara S, Takahashi H.
    Rinsho Byori; 2000 Dec; 48(12):1086-92. PubMed ID: 11215416
    [Abstract] [Full Text] [Related]

  • 12. Detection of shortened activated partial thromboplastin times: an evaluation of different commercial reagents.
    Ten Boekel E, Böck M, Vrielink GJ, Liem R, Hendriks H, de Kieviet W.
    Thromb Res; 2007 Dec; 121(3):361-7. PubMed ID: 17568658
    [Abstract] [Full Text] [Related]

  • 13. An assessment of the utility of unselected coagulation screening in general hospital practice.
    McHugh J, Holt C, O'Keeffe D.
    Blood Coagul Fibrinolysis; 2011 Mar; 22(2):106-9. PubMed ID: 21245744
    [Abstract] [Full Text] [Related]

  • 14. The lupus anticoagulant. High incidence of 'negative' mixing studies in a human immunodeficiency virus-positive population.
    Clyne LP, Yen Y, Kriz NS, Breitenstein MG.
    Arch Pathol Lab Med; 1993 Jun; 117(6):595-601. PubMed ID: 8503730
    [Abstract] [Full Text] [Related]

  • 15. [Interference of factor VIII excess on the detection of lupus anticoagulants by the activated partial thromboplastin time].
    Guermazi S, Gorgi Y, Ayed K, Dellagi K.
    Pathol Biol (Paris); 1997 Jan; 45(1):28-33. PubMed ID: 9097843
    [Abstract] [Full Text] [Related]

  • 16. Comparing the prothrombin time INR versus the APTT to evaluate the coagulopathy of acute trauma.
    Yuan S, Ferrell C, Chandler WL.
    Thromb Res; 2007 Jan; 120(1):29-37. PubMed ID: 16887171
    [Abstract] [Full Text] [Related]

  • 17. A Rare Cause of Isolated Prolonged Activated Partial Thromboplastin Time: An Overview of Prekallikrein Deficiency and the Contact System.
    Riano I, Prasongdee K.
    J Investig Med High Impact Case Rep; 2021 Jan; 9():23247096211012187. PubMed ID: 33940978
    [Abstract] [Full Text] [Related]

  • 18. Congenital bleeding disorders in Karachi, Pakistan.
    Borhany M, Shamsi T, Naz A, Khan A, Parveen K, Ansari S, Farzana T.
    Clin Appl Thromb Hemost; 2011 Jan; 17(6):E131-7. PubMed ID: 21247962
    [Abstract] [Full Text] [Related]

  • 19. [Development of factor VIII inhibitor in three non-hemophiliac patients].
    Kiguchi T, Niiya K, Yamawaki Y, Shima M, Harada M.
    Rinsho Ketsueki; 2000 Nov; 41(11):1195-200. PubMed ID: 11193439
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of primary haemostasis in people with neurofibromatosis type 1.
    Favaloro EJ, Zafer M, Nair SC, Hertzberg M, North K.
    Clin Lab Haematol; 2004 Oct; 26(5):341-5. PubMed ID: 15485464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.